At the news
? NEUTRALIMPACT 3/10 8-K filed Feb 27, 2026 at 06:05 ET
Analysis based on filing metadata only, document content was unavailable. The 8-K filing for Xeris Biopharma Holdings, Inc. (XERS) includes Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits), suggesting a possible investor presentation or public disclosure of material information, but no specific details or financial data are accessible to confirm content or implications.
- Filing is an 8-K for Xeris Biopharma Holdings, Inc. (XERS)
- Items reported: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
- No document content available to verify disclosures, financials, or strategic updates
- Exhibit 99.1 (press release or presentation) was likely filed but not accessible
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access